verified SJR 1,415 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed

New Zealand · Dove Medical Press Ltd.

workspace_premium Q1 — Oncology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Lung Cancer: Targets and Therapy

Lung Cancer: Targets and Therapy is a journal indexed in SJR in Oncology with an H index of 29. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1602 €. The scope of the journal is focused on lung cancer, palliative care, cancer screening. It has an SJR impact factor of 1,415 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,415.

Publisher: Dove Medical Press Ltd.

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,415 Q1

H-index 29

Acceptance rate pie_chart

41%

Source Acceptance_Rate

Time to publication hourglass_top

16 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.602 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

1,415

H-index

29

Docs (year)

19

Docs 3y

34

Total refs

608

Cites 3y

149

Citable 3y

26

Cites/Doc 2y

3.4

Ref/Doc

32.0

Immediate OA

1602 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review